Parkman Healthcare Partners LLC Bicycle Therapeutics PLC Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

A detailed history of Parkman Healthcare Partners LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 445,396 shares of BCYC stock, worth $6.54 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

445,396

Previous 535,063 16.76%

Holding current value

$6.54 Million

Previous $10.8 Million 6.72%

% of portfolio

1.43%

Previous 1.6%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.58 - $27.24 $1.76 Million - $2.44 Million	-89,667 Reduced 16.76%	445,396 $10.1 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $24.69 $216,416 - $266,898	10,810 Added 2.06%	535,063 $10.8 Million
Q1 2024 May 15, 2024	BUY	$16.75 - $26.1 $3.54 Million - $5.52 Million	211,364 Added 67.55%	524,253 $13.1 Million
Q4 2023 Feb 14, 2024	BUY	$13.29 - $22.2 $2.53 Million - $4.22 Million	190,168 Added 154.96%	312,889 $5.66 Million
Q3 2023 Nov 14, 2023	SELL	$19.9 - $26.25 $986,323 - $1.3 Million	-49,564 Reduced 28.77%	122,721 $2.47 Million
Q2 2023 Aug 11, 2023	BUY	$18.95 - $28.67 $464,009 - $702,013	24,486 Added 16.57%	172,285 $4.4 Million
Q1 2023 May 12, 2023	BUY	$20.02 - $31.37 $1.13 Million - $1.77 Million	56,467 Added 61.83%	147,799 $3.14 Million
Q4 2022 Feb 13, 2023	BUY	$20.37 - $32.9 $203,048 - $327,947	9,968 Added 12.25%	91,332 $2.7 Million
Q3 2022 Nov 14, 2022	BUY	$17.49 - $28.44 $366,205 - $595,476	20,938 Added 34.65%	81,364 $1.89 Million
Q2 2022 Aug 12, 2022	BUY	$12.95 - $46.99 $40,546 - $147,125	3,131 Added 5.46%	60,426 $1.01 Million
Q1 2022 May 13, 2022	SELL	$40.12 - $59.5 $301,100 - $446,547	-7,505 Reduced 11.58%	57,295 $2.51 Million
Q4 2021 Feb 11, 2022	SELL	$41.7 - $61.14 $198,033 - $290,353	-4,749 Reduced 6.83%	64,800 $3.94 Million
Q3 2021 Nov 12, 2021	SELL	$27.95 - $44.24 $315,555 - $499,469	-11,290 Reduced 13.97%	69,549 $2.89 Million
Q2 2021 Aug 13, 2021	BUY	$27.0 - $32.28 $145,395 - $173,827	5,385 Added 7.14%	80,839 $2.45 Million
Q1 2021 May 14, 2021	BUY	$19.12 - $30.25 $1.44 Million - $2.28 Million	75,454 New	75,454 $2.25 Million

Others Institutions Holding BCYC

# of Institutions

111

Shares Held

40.8M

Call Options Held

39.6K

Put Options Held

24.6K

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Bicycle Therapeutics PLC Transaction History